Hameln rds is a well-recognised pharmaceutical service provider for the health-care industry that benefits from combining German investment and Slovak scientific expertise.
hameln rds
Horná 36, 900 01 Modra, Slovakia
+421 (0)33 690 4402
m.takac@hameln-rds.sk
“We focus on different steps during the development and production of pharmaceutical products,” said Marian Takáč, CEO for Commercial Operations and Member of the Executive Management Board of hameln rds. “We are covering the analytical and galenical development of pharmaceuticals, Quality Control Services, as well as the development and GMP manufacturing of APIs.”
ENTERING GENERICS DEVELOPMENT
hameln rds
The Kerstein family of pharmacists founded their first pharmacy in the Lower Saxony town of Hamelin 120 years ago. For a long time, it ordered the development of generic medicines from foreign companies; they themselves only had production and sales in Germany. It was Slovakia that pushed hameln rds into the development of generic pharmaceuticals.
hameln rds
Established in 1995
Offices in Slovakia: Modra
Employees: 135
Revenues (2023): €35.7 million
Range of services: analytical and galenical development of pharmaceuticals, quality control and laboratory services (stability, batch release, biologics), development and GMP production of APIs, regulatory affairs
Via the acquisition of the Drug Research Institute located in Modra, western Slovakia, in 2006, the German pharmaceutical company acquired the services of a group of experienced scientists in Slovakia. In turn, the company significantly modernised and streamlined the facility in Modra. It renamed it hameln rds, the initials standing for ‘research development supply chain’.
Between 2012 and 2014, the company built its first unit for the production of high potency active pharmaceutical ingredients under Good Manufacturing Practice (GMP) conditions. A second production unit was added in 2020. Between 2017 and 2023, a new Microbiology and Central Receiving of Substances Unit was constructed. It changed the flow of raw materials and people within the company, which is important from a GMP perspective.
hameln rds
A unique investment was the Isolator Technology in the quality control laboratories, approved in 2023. In these laboratories, the company’s scientists are able to work with high-potency substances in a way that is safe for people and the surrounding environment. Today, hameln rds is an important manufacturer of active substances like painkillers and muscle relaxants, mainly used in the fields of intensive, emergency and palliative medicine. It has a unique position within the group. Hameln has three locations – in Germany, the UK and Slovakia – but Modra is the only place with laboratories and API production. The Modra-based company has two distinctive sectors today, said Marián Gono, CEO for Technical Operations and Member of the Executive Management Board of hameln rds. The first is the Active Pharmaceutical Ingredients sector, within which it carries out development and production under GMP conditions. The second significant sector is the Quality Control sector, where it performs several activities. These include standard quality control services, i.e. stability studies for pharmaceutical formulations, as well as analytical method development and analytical method validation.
MILESTONES
1972 | Foundation of the Drug Research Institute as an independent institution of Czechoslovak pharmaceutical producer Spofa with its office location in Hlohovec |
1977 | Main headquarters of the institute moves from Hlohovec to Modra |
1989 | Construction of new buildings in Modra completed |
1991 | The Biological Research Section and the Analytical Chemistry Section are awarded with a Certificate of Good Laboratory Praxis (GLP). The institute became the first organisation in Slovakia to obtain a GLP certificate |
1996 | Transformation of the Drug Research Institute from a state enterprise into the VULM joint-stock company. Slovakofarma became the main shareholder, holding 51% of the equity |
2006 | Acquisition of 100% of the shares of VULM by hameln rds GmbH |
2007 | Name of company changed to hameln rds |
2020 | Legal change of the company from joint stock company to limited liability company hameln rds s.r.o. part of hameln group |
This article has been brought to you by hameln rds s. r. o.
hameln rds
